Admission Date:  [**2103-4-11**]              Discharge Date:   [**2103-4-17**]  Date of Birth:  [**2052-9-17**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 668**] Chief Complaint: hemoperitoneum  Major Surgical or Invasive Procedure: none   History of Present Illness: Pt is a 50M with HCC (4.5 cm) in R lobe, s/p resection.
DM-II  Social History: no EtOH, no tobacco  Family History: mother: h/o uterine cancer sister: uterine cancer  Physical Exam: 98.1, 81, 104/64, 11 97% AOx3 RRR CTA B/L soft, NT, ND guiac +, nl tone  Pertinent Results: [**2103-4-10**] 11:26AM   WBC-6.2# RBC-2.89*# HGB-9.9*# HCT-28.2*# MCV-98 MCH-34.4* MCHC-35.2* RDW-15.8* [**2103-4-10**] 11:26AM   TOT BILI-6.9* DIR BILI-1.4* INDIR BIL-5.5 .
CT PELVIS W/CONTRAST  [**2103-4-10**] 3:22 PM CT ABD W&W/O C; CT PELVIS W/CONTRAST IMPRESSION: Large amount of new high-density free fluid within the abdomen consistent with hemoperitoneum suggesting rupture or bleeding from a hepatoma.
These findings were directly communicated to Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] at the moment of the interpretation of the study [**4-11**], [**2102**], at 10 a.m.
Otherwise, there are no new findings compared to prior study dated [**2103-4-6**].
Serial hematocrits were followed.
On HD 2 the patient and his hematocrits were stable and he was subsequently transfered to the floor.
A fever work-up was undertaken which ultimately to not reveal any abnormalities.
On [**4-17**] the patient was tolerating a regular diet, had decrease in abdominal pain, a stable hematocrit and he was subsequently discharged home.
Disp:*21 Tablet(s)* Refills:*0*   Discharge Disposition: Home  Discharge Diagnosis: 1. metastatic hepatocellular carcinoma 2. hepatitis B 3.
